Correlation between serum uric acid levels and clinical characteristics in patients with longitudinally extensive transverse myelitis A case-control study

被引:0
作者
Xiaofan You1
机构
基金
中国国家自然科学基金;
关键词
uric acid; longitudinally extensive transverse myelitis; neuromyelitis optica; neuromyelitis optica-IgG; auto-antibody;
D O I
暂无
中图分类号
R744.51 [];
学科分类号
1002 ;
摘要
Uric acid is reduced in demyelinating diseases,including multiple sclerosis and neuromyelitis optica(NMO).Longitudinally extensive transverse myelitis(LETM)is often an early manifestation of NMO.Whether uric acid levels are reduced at presentation of LETM remains unknown.The present study investigated serum uric acid levels by evaluating 35 patients with LETM,64 with NMO,62 with multiple sclerosis,63 with other neurological diseases and 65 healthy controls.In addition,we tested the correlation between serum uric acid and the clinical characteristics of LETM.All patients were in the acute phase,defined as less than 1 month from onset or relapse.The results revealed that serum uric acid levels in LETM were significantly lower than in multiple sclerosis,other neurological diseases and healthy controls,but no difference was found between LETM and NMO.A negative correlation between uric acid levels and Expanded Disability Status Scale scores was found in LETM patients(r=-0.545,P<0.05).The results suggest that uric acid levels are reduced in patients with LETM,raising the possibility that lower uric acid levels are an indicator of disease disability.Moreover,reduced uric acid levels may be a risk factor in NMO.
引用
收藏
页码:150 / 154
页数:5
相关论文
共 13 条
  • [1] NEUROLOGICAL AUTOIMMUNITY TARGETING AQUAPORIN-4
    Hinson, S. R.
    McKeon, A.
    Lennon, V. A.
    [J]. NEUROSCIENCE, 2010, 168 (04) : 1009 - 1018
  • [2] Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica
    Saikali, Philippe
    Cayrol, Romain
    Vincent, Thierry
    [J]. AUTOIMMUNITY REVIEWS, 2009, 9 (02) : 132 - 135
  • [3] Neuromyelitis optica: Effect of gender[J] . Dean M. Wingerchuk.Journal of the Neurological Sciences . 2009 (1)
  • [4] Uricase based methods for determination of uric acid in serum
    Yunsheng Zhao
    Xiaoyan Yang
    Wei Lu
    Hong Liao
    Fei Liao
    [J]. Microchimica Acta, 2009, 164 : 1 - 6
  • [5] Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity[J] . R.E. Gonsette.Journal of the Neurological Sciences . 2008 (1)
  • [6] Variation of serum uric acid levels in multiple sclerosis during relapses and immunomodulatory treatment
    Guerrero, A. L.
    Martin-Polo, J.
    Laherran, E.
    Gutierrez, F.
    Iglesias, F.
    Tejero, M. A.
    Rodriguez-Gallego, M.
    Alcazar, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : 394 - 397
  • [7] The spectrum of neuromyelitis optica
    Wingerchuk, Dean M.
    Lennon, Vando A.
    Lucchinetti, Claudia F.
    Pittock, Seanj
    Weinshenker, Brian G.
    [J]. LANCET NEUROLOGY, 2007, 6 (09) : 805 - 815
  • [8] Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity
    Du, Yangzhou
    Chen, Christopher P.
    Tseng, Chia-Yi
    Eisenberg, Yuval
    Firestein, Bonnie L.
    [J]. GLIA, 2007, 55 (05) : 463 - 472
  • [9] Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”[J] . Chris H.Polman,Stephen C.Reingold,GillesEdan,MassimoFilippi,Hans‐PeterHartung,LudwigKappos,Fred D.Lublin,Luanne M.Metz,Henry F.McFarland,Paul W.O’Connor,MagnhildSandberg‐Wollheim,Alan J.Thompson,Brian G.Weinshenker,Jerry S.Wolinsky.Ann Neurol. . 2005 (6)
  • [10] Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action[J] . Cinthia Farina,Martin S Weber,Edgar Meinl,Hartmut Wekerle,Reinhard Hohlfeld.Lancet Neurology . 2005 (9)